terazosin has been researched along with propranolol in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (11.54) | 18.7374 |
1990's | 4 (15.38) | 18.2507 |
2000's | 11 (42.31) | 29.6817 |
2010's | 8 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kagiya, T; Karliner, JS; Simpson, PC | 1 |
Bishopric, NH; Ordahl, CP; Simpson, PC | 1 |
Alibali, P; Bump, T; Carroll, JD; Coggins, DL; Feldman, M; Feldman, T; Gray, KR; Munkenbeck, F | 1 |
Simpson, P | 1 |
Abrahams, TP; Liu, W; Varner, KJ | 1 |
Bishopric, NH; Pratt, RE; Wu, CF | 1 |
Koman, LA; Li, Z; Pollock, DC; Rosencrance, E; Smith, BP; Smith, TL; Strandhoy, JW | 1 |
Antic, V; Kiener-Belforti, F; Montani, JP; Tempini, A; Van Vliet, BN | 1 |
Brands, MW; Fitzgerald, SM | 1 |
Brands, MW; Claxton, CR | 1 |
Brandon, E; da Silva, AA; do Carmo, JM; Dubinion, J; Hall, JE; Kanyicska, B | 1 |
Friedman, GD; Habel, LA; Udaltsova, N | 1 |
Dobrzański, G; Kwiatkowska, K; Pradel, K; Przewłocki, R; Solecki, WB; Szklarczyk, K | 1 |
Anderson, CD; Ge, Y; Granger, JP; Haynes, BP; Spradley, FT | 1 |
1 review(s) available for terazosin and propranolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
25 other study(ies) available for terazosin and propranolol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of pertussis toxin on alpha 1-agonist-mediated phosphatidylinositide turnover and myocardial cell hypertrophy in neonatal rat ventricular myocytes.
Topics: Adenosine Diphosphate Ribose; Animals; Animals, Newborn; Cell Division; Cells, Cultured; Inositol Phosphates; Myocardium; Norepinephrine; Pertussis Toxin; Phosphatidylinositols; Prazosin; Propranolol; Rats; Receptors, Adrenergic, alpha; Virulence Factors, Bordetella; Yohimbine | 1990 |
Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes.
Topics: Actins; Animals; Cardiomegaly; Cells, Cultured; Dose-Response Relationship, Drug; Isoproterenol; Myocardial Contraction; Norepinephrine; Prazosin; Propranolol; Rats; Receptors, Adrenergic, alpha; RNA, Messenger | 1987 |
Hemodynamic recovery during simulated ventricular tachycardia: role of adrenergic receptor activation.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Female; Ganglia, Autonomic; Heart Ventricles; Hemodynamics; Hexamethonium Compounds; Hypotension; Male; Myocardial Contraction; Prazosin; Pressoreceptors; Propranolol; Tachycardia | 1988 |
Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating.
Topics: Animals; Ascorbic Acid; Cardiomegaly; Cell Division; Cells, Cultured; Cycloheximide; Dopamine; Heart; Muscle Proteins; Myocardial Contraction; Myocardium; Piperazines; Prazosin; Propranolol; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Sympathomimetics | 1985 |
Blockade of alpha-2 adrenergic receptors in the rostral ventrolateral medulla attenuates the sympathoinhibitory response to cocaine.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Pressure; Cocaine; Idazoxan; Male; Medulla Oblongata; Microinjections; Piperoxan; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Sympatholytics | 1996 |
Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Animals; Animals, Newborn; Apoptosis; Atrial Natriuretic Factor; Cell Nucleus; Cells, Cultured; Cyclic GMP; Desmin; DNA Fragmentation; Dose-Response Relationship, Drug; Heart; Kinetics; Myeloid Cell Leukemia Sequence 1 Protein; Myocardium; Neoplasm Proteins; Nitroprusside; Norepinephrine; Phosphodiesterase Inhibitors; Polymerase Chain Reaction; Prazosin; Propranolol; Proto-Oncogene Proteins c-bcl-2; Purinones; Rats; Receptors, Atrial Natriuretic Factor | 1997 |
Effect of cooling on cutaneous microvascular adrenoceptors in vivo in the rabbit ear.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arterioles; Cold Temperature; Dose-Response Relationship, Drug; Ear; Male; Microcirculation; Norepinephrine; Peripheral Nerves; Prazosin; Propranolol; Rabbits; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Regional Blood Flow; Skin; Vasoconstriction; Venules | 1998 |
Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Blood Pressure Determination; Dietary Fats; Glomerular Filtration Rate; Heart Rate; Hypertension; Injections, Intravenous; Kidney; Male; Obesity; Phenylephrine; Prazosin; Propranolol; Rabbits; Sodium; Sympathetic Nervous System; Sympathomimetics; Telemetry | 2000 |
Hypertension in L-NAME-treated diabetic rats depends on an intact sympathetic nervous system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin II; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glomerular Filtration Rate; Hypertension, Renal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Sodium; Sympathetic Nervous System | 2002 |
Nitric oxide opposes glucose-induced hypertension by suppressing sympathetic activity.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Enzyme Inhibitors; Glucose; Heart Rate; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Renin; Sympathetic Nervous System | 2003 |
Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats.
Topics: Adrenergic alpha-Antagonists; Agouti-Related Protein; Animals; Antihypertensive Agents; Blood Pressure; Eating; Female; Heart Rate; Hypertension, Renal; Hypothalamus; Male; Melanocortins; Melanocyte-Stimulating Hormones; Neuropeptide Y; Prazosin; Pro-Opiomelanocortin; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Leptin; RNA, Messenger; Sympathetic Nervous System | 2008 |
Norepinephrine antagonists and cancer risk.
Topics: Atenolol; Breast Neoplasms; Clonidine; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Male; Metoprolol; Neoplasms; Norepinephrine; Odds Ratio; Prazosin; Propranolol; Prostatic Neoplasms; Risk Assessment | 2011 |
Noradrenergic signaling in the VTA modulates cocaine craving.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Behavior, Animal; Cocaine; Conditioning, Operant; Craving; Dopamine Uptake Inhibitors; Drug-Seeking Behavior; Idazoxan; Male; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Self Administration; Ventral Tegmental Area | 2018 |
Adrenergic receptor blockade attenuates placental ischemia-induced hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Female; Ischemia; Placenta; Prazosin; Pre-Eclampsia; Pregnancy; Propranolol; Rats; Rats, Wistar | 2018 |